0001209191-24-002427.txt : 20240130
0001209191-24-002427.hdr.sgml : 20240130
20240130170404
ACCESSION NUMBER: 0001209191-24-002427
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240127
FILED AS OF DATE: 20240130
DATE AS OF CHANGE: 20240130
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Nguyen Diem
CENTRAL INDEX KEY: 0001814338
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38436
FILM NUMBER: 24579065
MAIL ADDRESS:
STREET 1: C/O VERRICA PHARMACEUTICALS INC.
STREET 2: 10 NORTH HIGH STREET, SUITE 200
CITY: WEST CHESTER
STATE: PA
ZIP: 19380
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: SIGA TECHNOLOGIES INC
CENTRAL INDEX KEY: 0001010086
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 133864870
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 31 EAST 62ND STREET
CITY: NEW YORK
STATE: NY
ZIP: 10065
BUSINESS PHONE: 212-672-9100
MAIL ADDRESS:
STREET 1: 31 EAST 62ND STREET
CITY: NEW YORK
STATE: NY
ZIP: 10065
FORMER COMPANY:
FORMER CONFORMED NAME: SIGA PHARMACEUTICALS INC
DATE OF NAME CHANGE: 19961108
4
1
doc4.xml
FORM 4 SUBMISSION
X0508
4
2024-01-27
0
0001010086
SIGA TECHNOLOGIES INC
SIGA
0001814338
Nguyen Diem
C/O SIGA TECHNOLOGIES, INC.
31 EAST 62ND STREET
NEW YORK
NY
10065
1
1
0
0
Chief Executive Officer
0
Stock Option (Right to buy)
5.06
2024-01-27
4
A
0
109606
0.00
A
2034-01-27
Common Stock, par value $.0001 per share
109606
109606
D
Stock Option (Right to buy)
5.06
2024-01-27
4
A
0
219212
0.00
A
2034-01-27
Common Stock, par value $.0001 per share
219212
219212
D
Restricted Stock Units
2024-01-27
4
A
0
167707
0.00
A
Common Stock, par value $.0001 per share
167707
167707
D
Performance Stock Units
2024-01-27
4
A
0
177865
0.00
A
Common Stock, par value $.0001 per share
177865
177865
D
The options vest over two years, one-half on each of the first two anniversaries of the date of grant.
The options vest over three years, one-third on each of the first three anniversaries of the date of grant.
Restricted stock units ("RSUs") represent contingent rights to receive Common Stock on a one-for-one basis. The RSUs vest over three years, one-third on each of the first three anniversaries of the date of grant.
Performance stock units ("PSUs") represent contingent rights to receive Common Stock on a one-for-one basis. These PSUs vest as follows: (a) one-third of these PSUs vest if, during any period of 90 consecutive trading days during the three-year period beginning on the grant date (the "Performance Period"), the Issuer's Common Stock closing stock price (plus the per share value of any dividends issued during the measurement date) (the "Stock Price") is at or above $7.00, (b) one-third of these PSUs vest, if during any period of 90 consecutive trading days during the Performance Period, the Stock Price is at or above $8.00, and (c) one-third of these PSUs vest, if during any 90 consecutive trading days during the Performance Period, the Stock Price is at or above $9.00.
/s/ Diem Nguyen
2024-01-30